Inceptionr LLC Sells 1,770 Shares of Cigna Group $CI

Inceptionr LLC lowered its holdings in Cigna Group (NYSE:CI) by 56.6% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,355 shares of the health services provider’s stock after selling 1,770 shares during the quarter. Inceptionr LLC’s holdings in Cigna Group were worth $361,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the business. Gibbs Wealth Management raised its holdings in shares of Cigna Group by 137.3% in the 1st quarter. Gibbs Wealth Management now owns 6,965 shares of the health services provider’s stock worth $1,858,000 after acquiring an additional 4,030 shares during the last quarter. Sei Investments Co. boosted its stake in Cigna Group by 83.6% during the 1st quarter. Sei Investments Co. now owns 865,893 shares of the health services provider’s stock valued at $230,976,000 after purchasing an additional 394,294 shares during the last quarter. Keynote Financial Services LLC boosted its stake in Cigna Group by 3.0% during the 1st quarter. Keynote Financial Services LLC now owns 3,058 shares of the health services provider’s stock valued at $816,000 after purchasing an additional 89 shares during the last quarter. State of Wyoming increased its holdings in Cigna Group by 10.4% during the 1st quarter. State of Wyoming now owns 3,045 shares of the health services provider’s stock worth $812,000 after purchasing an additional 286 shares in the last quarter. Finally, Cetera Investment Advisers raised its stake in shares of Cigna Group by 14.3% in the first quarter. Cetera Investment Advisers now owns 83,442 shares of the health services provider’s stock worth $22,258,000 after purchasing an additional 10,408 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Stock Performance

NYSE CI opened at $291.35 on Tuesday. The company has a market capitalization of $77.07 billion, a PE ratio of 12.35, a price-to-earnings-growth ratio of 1.12 and a beta of 0.29. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. Cigna Group has a 52-week low of $239.51 and a 52-week high of $315.47. The company has a 50-day simple moving average of $286.15 and a 200 day simple moving average of $280.80.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm had revenue of $68.52 billion for the quarter, compared to analysts’ expectations of $66.29 billion. During the same period in the previous year, the company earned $6.74 earnings per share. The company’s quarterly revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, research analysts predict that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be paid a $1.56 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 annualized dividend and a yield of 2.1%. Cigna Group’s dividend payout ratio is presently 26.45%.

Analyst Upgrades and Downgrades

CI has been the topic of several analyst reports. Wolfe Research reaffirmed an “outperform” rating and set a $315.00 target price on shares of Cigna Group in a research report on Tuesday, June 16th. Jefferies Financial Group cut their price objective on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a report on Monday, April 20th. Piper Sandler reduced their target price on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a research note on Wednesday, June 3rd. Royal Bank Of Canada increased their target price on shares of Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a report on Friday, May 1st. Finally, Robert W. Baird set a $337.00 price target on shares of Cigna Group in a research report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $338.80.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the transaction, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer owned 2,368 shares in the company, valued at approximately $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is currently owned by corporate insiders.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.